Dr. Martin-Yeboah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
185 Central Ave
Suite 601
East Orange, NJ 07018Phone+1 973-944-1089Fax+1 973-866-0023
Education & Training
Rutgers Health/Newark Beth Israel Medical CenterResidency, Pediatrics, 1992 - 1995
University of Ghana Medical SchoolClass of 1976
Certifications & Licensure
NJ State Medical License 1995 - 2025- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 39 citationsCD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunityFrancesca Zammarchi, Karin Havenith, Francois Bertelli, Balakumar Vijayakrishnan, Simon Chivers
Journal for Immunotherapy of Cancer. 2020-09-01 - 106 citationsADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignancies.Francesca Zammarchi, Simon Corbett, Lauren Adams, Peter Tyrer, Konstantinos Kiakos
Blood. 2018-03-08 - 74 citationsPre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine.John A. Hartley, Michael Flynn, John Bingham, Simon Corbett, Halla W. Reinert
Scientific Reports. 2018-07-11
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
